(Reuters) -Eli Lilly ( LLY ) on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound and type 2 diabetes drug Mounjaro. Shares of the company rose 3.6% premarket. Sky-rocketing demand for Mounjaro and Zepbound, both chemically known as tirzepatide, has propelled the drugmaker's market value to over $700 billion - surpassing that of...

06:48 AM EDT, 04/30/2024 (MT Newswires) -- Enterprise Products Partners ( EPD ) reported Q1 earnings Tuesday of $0.66 per diluted unit, up from $0.63 a year earlier. Analysts polled by Capital IQ expected $0.67. Revenue for the quarter ended March 31 was $14.76 billion, up from $12.44 billion a year earlier. Analysts surveyed by Capital IQ expected $13.82 billion....

April 30 (Reuters) - Eli Lilly ( LLY ) beat Wall Street estimates for first-quarter profit on Tuesday, helped by rising demand for its weight-loss treatment Zepbound and type 2 diabetes drug Mounjaro. The Indianapolis-based drugmaker posted a profit of $2.58 per share on an adjusted basis, compared with analysts' expectations of $2.46 per share, according to LSEG data. (Reporting...

(Reuters) - The U.S. Federal Trade Commission has asked for more information from Vizio ( VZIO ) and Walmart ( WMT ) regarding their proposed $2.3 billion deal, the smart-TV maker said on Tuesday. U.S. lawmakers have sought for an increased scrutiny from the FTC on many multi-billion dollar deals that might risk higher prices and affect consumers. Several deals...